Studies on the survival and inactivation of herpes simplex virus type 1 on coins
Bardell, D.
Microbios 77(312): 161-166
1994
ISSN/ISBN: 0026-2633 PMID: 8170405 Document Number: 422927
Survival of herpes simplex virus type 1 (HSV-1) in saliva at room temperature (21-23 degrees C) on 1, 5, 10, and 25 cent coins was studied. There was little or no loss of infectious HSV-1 before 30 min. Between 30 and 60 min there was a 2- to 3-log drop in titre, and with the exception of the 1 cent coin, some infectious virus was still present after 2 h, the longest period studied. The most conspicuous drop in titre occurred with loss of moisture from the saliva. In addition to the drying process, the metals of the coins also contributed to the decline in titre of HSV-1.
Document emailed within 1 workday
Related Documents
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Roohandeh, M.; Bamdad, T. 2011: Inactivation of Herpes Simplex Virus type 1 & Adenovirus Type 5 by Direct Electric Current at a Biocompatible Level in Vitro Clinical Laboratory 57(7-8): 489-495
Colette Smit, C.P.,A.M.,J.T.,J.S.,B.B.,R.C.andN.H.T.M.D. 2007: Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and Hiv over time (19842003) European Journal of Epidemiology 22(12): 937-944
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610
Biesiadecka, A. 2000: Immunogenic activity of temperature sensitive mutation of herpes simplex virus type-1 in mono- and polyvalent conditions with different attenuated strains of virus. I. Analysis of humoral immunity induced by mutant temperature sensitive herpes simplex virus type-1 in monovalent systems Medycyna Doswiadczalna i Mikrobiologia 52(1): 81-88
Bardell, D. 1990: Survival of herpes simplex virus type 1 on some frequently touched objects in the home and public buildings Microbios 63: 256-257
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
Schneweis, K.E.; Nahmias, A.J. 1971: Antigens of Herpes simplex virus type 1 and 2-immunodiffusion and inhibition passive hemagglutination studies Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 141(5): 471-487
Timbury, M.C.; Hay, J. 1975: Genetic and physiological studies with herpes simplex virus type 2 temperature-sensitive mutants Iarc Scientific Publications 1975(11 Pt 1): 219-225
Parr, M.B.; Kepple, L.; McDermott, M.R.; Drew, M.D.; Bozzola, J.J.; Parr, E.L. 1994: A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2 Laboratory Investigation; a Journal of Technical Methods and Pathology 70(3): 369-380
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264
Piret, J.; Roy, S.; Gagnon, Mène.; Landry, Sébastien.; Désormeaux, Aé.; Omar, R.F.; Bergeron, M.G. 2002: Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine Antimicrobial Agents and ChemoTherapy 46(9): 2933-2942
Scoular, A.; Leask, B.G.; Carrington, D. 1990: Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88 Genitourinary Medicine 66(3): 226
Slomka, M.J. 1996: Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus Communicable Disease Report. Cdr Review 6(3): R41-R45
Abe, Y.; Kobayashi, S. 1982: The DNA restriction enzyme analyses of herpes simplex virus type 1 isolates from cases of ocular herpes Nippon Ganka Gakkai Zasshi 86(8): 867-869
Kruglova, A.I.; Nikolaeva, N.P.; Niukhalova, I.V.; Barinskiĭ, I.F.; Alimbarova, L.M.; Demkin, V.V. 2004: Polymorphism of herpes simplex virus type 1 and 2 DNA from laboratory strains and clinical material from patient with genital herpes Voprosy Virusologii 49(1): 23-27
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Prober, C.G.; Sullender, W.M.; Yasukawa, L.L.; Au, D.S.; Yeager, A.S.; Arvin, A.M. 1987: Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections New England Journal of Medicine 316(5): 240-244
Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844